Access To Medicine Foundation
  • Who we are
  • What we do
  • Impact
  • Insights & resources
  • News & events
  • Donate
Donate

Who we are

An independent non-profit organisation accelerating progress toward global health equity.

  • About us
  • How we drive change
  • Our strategy 2022 - 2026
  • Governance
  • Team
  • Funders
  • Annual reports

What we do

We catalyse progress toward equitable access to essential medicines in low- and middle-income countries through our work across diverse research areas.

  • R&D-based pharma companies
  • Medical gas companies
  • Generic medicine manufacturers
  • Diagnostics companies
  • Vaccine manufacturers
  • Antimicrobial resistance
  • Diabetes care

Impact

Discover how our work drives real-world progress on access to medicine.

  • Our achievements
  • Voices of our community
  • How we drive change
  • Partner with us

Insights & resources

Discover our evidence-based research, insights and other changemaking tools.

  • Research hub
  • Company profiles & report cards
  • Access insights
  • The Health Equity podcast
  • Health Equity through Her Lens

News & events

Stay informed on our latest events, collaborations, engagements, and Foundation news.

  • News
  • Events & engagements
  • In the media

Follow us

Often searched

Index ranking

Vacancies

10 year analysis

Follow us

  • About us
  • How we drive change
  • Our strategy 2022 - 2026
  • Governance
  • Team
  • Funders
  • Annual reports
  • R&D-based pharma companies
  • Medical gas companies
  • Generic medicine manufacturers
  • Diagnostics companies
  • Vaccine manufacturers
  • Antimicrobial resistance
  • Diabetes care
  • Our achievements
  • Voices of our community
  • How we drive change
  • Partner with us
  • Research hub
  • Company profiles & report cards
  • Access insights
  • The Health Equity podcast
  • Health Equity through Her Lens
  • News
  • Events & engagements
  • In the media

Fortune: Gasping for breath: Covid-19 exposes medical oxygen crisis and need for industry action

In this viewpoint for Fortune Magazine, Access to Medicine Foundation Executive Director Jayasree K. Iyer addresses the urgent need for medical oxygen in low- and middle-income countries (LMICs), examining the role of pharmaceutical companies and how existing needs amplified due to COVID-19.

Date

15 February 2021

Direct links

Read the full viewpoint

Acknowledging progress made by pharmaceutical companies on the broader issue of access to medicine, Jayasree highlights how the pandemic has worsened an already unmet need for medical oxygen. Oxygen is used as treatment for a wide range of diseases, such as pneumonia.

Oxygen is vital for treating other deadly conditions, including pneumonia, which claims the life of a child every 39 seconds.

In the viewpoint, Jayasree calls for action by pharma companies to improve supply of medical oxygen in LMICs while reducing its costs. As examples of how this could be done, Dr. Iyer points to existing endeavors by three of the five main medical oxgyen companies; furthermore, she underscores efforts from the Every Breath Counts Coalition and the Access to Medicine Foundation in engaging stakeholders and companies in an effort to improve access and delivery of medical oxygen where it is desperately needed.  

Read the full viewpoint here.

Access to Medicine Foundation

Subscribe to our newsletter

Vacancies FAQs Contact us

Follow us

Access to Medicine Foundation is funded by

Terms & conditions Privacy & cookie policy Disclaimer

Copyright 2004 - 2026 Access to Medicine Foundation - All Rights Reserved